Hematology - Oncology

Hematology-Oncology Medical Group of Orange County, Inc. Pomona, California... 

Nauseef, W. M. (1988). Myeloperoxidase deficiency. In Phagocytic Defects, vol. I (Hematology/Oncology Clinics of North America), pp. 135-58, W. B. Saunders, Philadelphia. 

Prof. Dr. Matthias Theobald Johannes Gutenberg-University Department of Hematology Oncology... 

Department of Hematology, Oncology, and Internal Diseases, Medical University of Warsaw, Warsaw, Poland... 

Johannes Gutenberg-University, Department of Hematology Oncology, Mainz, Germany... 

To whom correspondence shonld be addressed. Johannes Gutenberg-University, Department of Hematology Oncology, Mainz, Germany, E-Mail theobald 3-med.klinik.uni-mainz.de... 

Department of Internal Medicine, University of Arizona, Tucson AZ 85724, USA Hematology/Oncology Southern Arizona Veterans Aifairs Health Care System, Tucson, AZ 85723, USA... 

Lad TE. Post-surgical therapy in stage I, II, III A non-small cell lung cancer [Review], Hematology-Oncology Clinics of North America 1990 4 1111-1119. 

Jason H. Lee Hudner Oncology Center, St. Anne s Hospital, Fall River, MA Robert M. MacRae Ottawa Regional Cancer Centre, Ottawa, Ontario Stacy L. Moulder Department of Hematology-Oncology, Vanderbilt Medical Center, Nashville, TN... 

Stephen G. Swisher Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX Beverly A. Teicher Genzyme Corporation, Framingham, MA Everett E. Vokes Section of Hematology/Oncology, University of Chicago, Chicago, IL... 

Federico Innocenti, MD PhD University of Chicago Department of Medicine Section of Hematology/Oncology 5841 South Maryland Avenue Chicago IL 60637-1470 USA... 

Dong Hwan Kim, MD, PhD Department of Hematology/Oncology Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea... 

Federico Innocenti, MD, PhD Department of Medicine, Section of Hematology/ Oncology, University of Chicago, Chicago, Illinois, USA... 

Martin Stanulla, MD, MSc Pediatric Hematology Oncology, Hannover Medical School, Hannover, Germany... 

Department of Medicine, Division of Hematology Oncology, Wallace H. Coulter Platelet Laboratory, University of Miami School of Medicine, Miami, Florida 33136... 

Toshiyuki Kohno Laboratory of Structural Biology, Mitsubishi Kagaku Institute of Life Sciences (MITILS), Tokyo, Japan Kit S. Lam Division of Hematology Oncology, Department of Internal Medicine, UC Davis Cancer Center, University of California, Davis, CA Rob Lf.i irs Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research (LACDR), Faculty of Sciences, Vrije Universiteit, Amsterdam, The Netherlands... 

Shaoguang Li Division of Hematology Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA... 

Gerhard J. Johnson, M.D. University of Minnesota Medical School Staff Physician, Hematology/Oncology Section Veterans Affairs Medical Center Minneapolis, MN USA... 

Gerhard J. Johnson, M.D. is Professor of Medicine, University of Minnesota Medical School, and Staff Physician, Hematology/Oncology Section, Medical Service, Veterans Affairs Medical Center, Miimeapolis, Minnesota. His platelet research program, funded by VA Merit l view and NIH grants since 1972, has focused on the study of platelet signal transduction via thromboxane receptors, with emphasis on the study of dog platelets. He has served as Chairman of the VA Merit Review Board for Hematology and the Subcommittee on Animal Models of the Scientific and Standardization Committee, ISTH. 

Ashby B, DanielJL, and Smith JB. (1990). Mechanisms of platelet activation and inhibition. Hematology-Oncology Clinics of North America. 4,1-26. 

In a prospective study to evaluate the impact of a clinical pharmacist in outpatient hematology-oncology clinics, patient charts and profiles were reviewed and patient interviews were conducted to obtain medication historiesWithin a 36-day time period, 211 interventions were documented the majority of these interventions were not related to chemotherapy. The most frequent activities consisted of patient counseling and therapeutic recommendations. Of the problems identified, most were of high and moderate significance and pharmacy interventions yielded positive clinical outcomes. The physician acceptance rate to pharmacists interventions was 94.5%. 

An analysis of self-reported interventions by hematology-oncology pharmacists and staff was also performed to document pharmaceutical care interventions over a period of approximately 8 months at the Walter Reed Army Medical Center.The interventions were analyzed to determine the types of interventions that are most frequently performed, prescribing errors encountered, medication cost avoidance that resulted from the interventions and types of interventions that are associated with medication cost interventions, and intervention acceptance rate by physicians. Interventions were entered into a personal computer and analyzed using CliniTrend Web Support System software (ASHP). Medication cost avoidance was determined if less medication was used, an equally effective but less costly medication was used, or a medication that could not be reused was not prepared. 

Table 6 Summary of interventions reported by hematology-oncology pharmacists at Walter Reed Army Medical Center (October 1, 1995-May 31, 1996)...

Oncology Pediatrics Oncology Women s health Nephrology Hematology Oncology Women s health Men s health... 

---